tandospirone has been researched along with Experimental Hepatoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anker, SD; Beadle, J; Coats, AJ; Doehner, W; Elkina, Y; Hartmann, K; Mayer, U; Palus, S; Springer, J; Tschirner, A; von Haehling, S | 1 |
1 other study(ies) available for tandospirone and Experimental Hepatoma
| Article | Year |
|---|---|
Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Anti-Anxiety Agents; Body Composition; Cachexia; Carcinoma, Hepatocellular; Cell Line, Tumor; Echocardiography; Heart Function Tests; Isoindoles; Liver Neoplasms, Experimental; Male; Muscle, Skeletal; Piperazines; Pyrimidines; Rats; Rats, Wistar; Survival Rate; Ventricular Function, Left | 2013 |